The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

May 16 (Reuters) - Ozempic-maker Novo Nordisk (NOVOb.CO), opens new tab on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the ...

The Therapeutic Goods Administration has received complaints of blindness and vision loss in one eye among users of Ozempic and Wegovy, who are reluctant to ditch the weight-loss drugs.

Ozempic users find that it not only promotes weight loss but also helps lower the risk of heart disease, high blood pressure, type 2 diabetes, and other obesity-related conditions.

ONTARIO, Canada, May 16, 2025 (EZ Newswire) -- Canadian Insulin, today shared insights about Ozempic (semaglutide) and the high cost of prescription medications in the U.S., which has been a major ...

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle with giants Eli Lilly and Novo Nordisk for a share of the multibillion-dollar ...

The Daily Aus (TDA) has announced the launch of Investigating Ozempic — an original podcast series examining the soaring popularity of weight loss drugs and their impact on young Aussies.